GLP-1, peptides, and longevity: what the science says

Original video 110 minHere 3 min read
TL;DR

The popularity of GLP-1 drugs like semaglutide and growth hormone secretagogue peptides has grown exponentially in recent years. However, Dr. Valter Longo, a longevity researcher with over thirty years of experience, warns that focusing only on short-term effects can have serious long-term health consequences.

GLP-1: what long-term data reveals

GLP-1 receptor agonists produce rapid and visible weight loss, which explains their popularity. However, long-term data shows that 92% of users quit within three years and only 8% continue. The primary issue is the composition of the weight lost.

Muscle loss and the rebound effect

When losing weight with GLP-1, a significant amount of lean mass is lost alongside fat. Once the drug is stopped, weight is regained faster than with nutritional changes alone, because natural endogenous GLP-1 levels have decreased, similar to what happens with exogenous testosterone when discontinued.

The net result over four years for a person weighing 100 kilograms is, according to Dr. Longo's analysis, a loss of only about 3 kilograms of fat accompanied by a loss of 2 kilograms of lean mass, a balance that does not justify widespread use as a universal solution to obesity.

Growth hormone secretagogues: the longevity risk

A popular category of peptides currently stimulates the body to produce more growth hormone and, consequently, more IGF-1. Dr. Longo has spent decades studying this pathway and his conclusion is clear: excess GH and IGF-1 shortens life.

Evidence from humans and animals

People with growth hormone receptor deficiency (Laron syndrome) rarely develop cancer or diabetes and show cognitive profiles typical of individuals much younger. In mice, overactivation of the GH/IGF-1 pathway systematically shortens lifespan and is associated with more cardiovascular and metabolic disease.

Patients with acromegaly, who have chronically elevated levels, die younger and require drugs to reduce that signal. Longo compares using secretagogues to putting a high-performance engine in an old car: it may accelerate in the short term, but the system was not designed for that sustained effort.

Protein: how much and what type

High animal protein intake is another factor Longo identifies as problematic for longevity. Exceeding moderate levels (above 1.5 g/kg) with primarily animal protein raises IGF-1 to ranges that epidemiological data consistently links to higher cancer and cardiovascular mortality.

Harvard studies and the Lancet analysis confirm that low-carbohydrate diets high in animal fats and proteins are associated with higher overall mortality. Populations with historically high life expectancy, such as those in Okinawa, southern Italy, and Loma Linda, have consumed high-carbohydrate diets with a plant-to-animal protein ratio of 2:1 or greater.

For muscle building, data shows that the difference between 0.8 and 1.2 g/kg is small, and that strength training has a far more determinant effect than additional protein intake.

The fasting mimicking diet (FMD)

Dr. Longo proposes the fasting mimicking diet as an intervention with solid evidence accumulated across multiple clinical trials. It is a five-day protocol of caloric restriction (770 to 1,100 kcal/day), 100% plant-based, high in fats from olive oil and nuts, and low in sugar and protein.

Documented cellular regeneration

FMD cycles activate reprogramming factors that allow damaged cells in organs such as the pancreas and kidneys to recover their function. In a clinical trial with 13 chronic kidney disease patients, three FMD cycles significantly reduced proteinuria and tripled circulating progenitor cells, with effects maintained one year later.

Longo also suggests that briefly combining GLP-1 with FMD cycles could leverage the drug's appetite-suppressing effect early on, while minimizing its long-term side effects.

Conclusion

Longevity data does not support indiscriminate use of GLP-1 drugs or GH secretagogues as anti-aging strategies. Dr. Valter Longo advocates prioritizing lifestyle change guided by specialized professionals, with tools like the FMD, moderate and primarily plant-based protein, and strength training as the most solid path to a long and healthy life.

Knowledge offered by Simon Hill

Video thumbnail for GLP-1, peptides, and longevity: what the science says